Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial

BACKGROUND: The FACE-Q patient-reported outcome assesses patient experiences/outcomes with aesthetic facial procedure. A recent trial of abobotulinumtoxinA (ASI, liquid formulation) was the first to our knowledge to assess satisfaction with FACE-Q after glabellar line (GL) injection. OBJECTIVES: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascher, Benjamin, Rzany, Berthold, Kestemont, Philippe, Hilton, Said, Heckmann, Marc, Bodokh, Isaac, Noah, Ernst Magnus, Boineau, Dominique, Kerscher, Martina, Volteau, Magali, Le Berre, Philippe, Picaut, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Body Contouring
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427150/
https://www.ncbi.nlm.nih.gov/pubmed/31550352
http://dx.doi.org/10.1093/asj/sjz248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427150/
https://www.ncbi.nlm.nih.gov/pubmed/31550352
http://dx.doi.org/10.1093/asj/sjz248

Ejemplares similares